Global Zoster Vaccine Market Growth 2022-2028
- LP 4871365
- 71 Pages
- February 2022
- Pharmaceuticals
The United States Zoster Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Zoster Vaccine market, reaching US$ million by the year 2028. As for the Europe Zoster Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Zoster Vaccine players cover GSK, Merck, Sanofi Pasteur, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Zoster Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Live
Recombinant
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Government Institution
Private Sector
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Merck
Sanofi Pasteur
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Zoster Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Zoster Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Zoster Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Zoster Vaccine Segment by Type
2.2.1 Live
2.2.2 Recombinant
2.3 Zoster Vaccine Sales by Type
2.3.1 Global Zoster Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Zoster Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Zoster Vaccine Sale Price by Type (2017-2022)
2.4 Zoster Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Zoster Vaccine Sales by Application
2.5.1 Global Zoster Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Zoster Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Zoster Vaccine Sale Price by Application (2017-2022)
3 Global Zoster Vaccine by Company
3.1 Global Zoster Vaccine Breakdown Data by Company
3.1.1 Global Zoster Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Zoster Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Zoster Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Zoster Vaccine Revenue by Company (2020-2022)
3.2.2 Global Zoster Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Zoster Vaccine Sale Price by Company
3.4 Key Manufacturers Zoster Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Zoster Vaccine Product Location Distribution
3.4.2 Players Zoster Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Zoster Vaccine by Geographic Region
4.1 World Historic Zoster Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Zoster Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Zoster Vaccine Annual Revenue by Geographic Region
4.2 World Historic Zoster Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Zoster Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Zoster Vaccine Annual Revenue by Country/Region
4.3 Americas Zoster Vaccine Sales Growth
4.4 APAC Zoster Vaccine Sales Growth
4.5 Europe Zoster Vaccine Sales Growth
4.6 Middle East & Africa Zoster Vaccine Sales Growth
5 Americas
5.1 Americas Zoster Vaccine Sales by Country
5.1.1 Americas Zoster Vaccine Sales by Country (2017-2022)
5.1.2 Americas Zoster Vaccine Revenue by Country (2017-2022)
5.2 Americas Zoster Vaccine Sales by Type
5.3 Americas Zoster Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Zoster Vaccine Sales by Region
6.1.1 APAC Zoster Vaccine Sales by Region (2017-2022)
6.1.2 APAC Zoster Vaccine Revenue by Region (2017-2022)
6.2 APAC Zoster Vaccine Sales by Type
6.3 APAC Zoster Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Zoster Vaccine by Country
7.1.1 Europe Zoster Vaccine Sales by Country (2017-2022)
7.1.2 Europe Zoster Vaccine Revenue by Country (2017-2022)
7.2 Europe Zoster Vaccine Sales by Type
7.3 Europe Zoster Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Zoster Vaccine by Country
8.1.1 Middle East & Africa Zoster Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Zoster Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Zoster Vaccine Sales by Type
8.3 Middle East & Africa Zoster Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Zoster Vaccine
10.3 Manufacturing Process Analysis of Zoster Vaccine
10.4 Industry Chain Structure of Zoster Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Zoster Vaccine Distributors
11.3 Zoster Vaccine Customer
12 World Forecast Review for Zoster Vaccine by Geographic Region
12.1 Global Zoster Vaccine Market Size Forecast by Region
12.1.1 Global Zoster Vaccine Forecast by Region (2023-2028)
12.1.2 Global Zoster Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Zoster Vaccine Forecast by Type
12.7 Global Zoster Vaccine Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Zoster Vaccine Product Offered
13.1.3 GSK Zoster Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Zoster Vaccine Product Offered
13.2.3 Merck Zoster Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Zoster Vaccine Product Offered
13.3.3 Sanofi Pasteur Zoster Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
14 Research Findings and Conclusion
Table 1. Zoster Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Zoster Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Live
Table 4. Major Players of Recombinant
Table 5. Global Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Zoster Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Zoster Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Zoster Vaccine Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Zoster Vaccine Revenue by Application (2017-2022)
Table 13. Global Zoster Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Zoster Vaccine Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Zoster Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Zoster Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Zoster Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Zoster Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Zoster Vaccine Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Zoster Vaccine Producing Area Distribution and Sales Area
Table 21. Players Zoster Vaccine Products Offered
Table 22. Zoster Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Zoster Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Zoster Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Zoster Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Zoster Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Zoster Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Zoster Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Zoster Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Zoster Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Zoster Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Zoster Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Zoster Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Zoster Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Zoster Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Zoster Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Zoster Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Zoster Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Zoster Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Zoster Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Zoster Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Zoster Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Zoster Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Zoster Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Zoster Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Zoster Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Zoster Vaccine
Table 66. Key Market Challenges & Risks of Zoster Vaccine
Table 67. Key Industry Trends of Zoster Vaccine
Table 68. Zoster Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Zoster Vaccine Distributors List
Table 71. Zoster Vaccine Customer List
Table 72. Global Zoster Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Zoster Vaccine Sales Market Forecast by Region
Table 74. Global Zoster Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Zoster Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Zoster Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Zoster Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Zoster Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Zoster Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Zoster Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Zoster Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Zoster Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Zoster Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Zoster Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Zoster Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Zoster Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Zoster Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Zoster Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Zoster Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Zoster Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Zoster Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. GSK Basic Information, Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Zoster Vaccine Product Offered
Table 94. GSK Zoster Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Merck Basic Information, Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Zoster Vaccine Product Offered
Table 99. Merck Zoster Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Sanofi Pasteur Basic Information, Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Pasteur Zoster Vaccine Product Offered
Table 104. Sanofi Pasteur Zoster Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Pasteur Main Business
Table 106. Sanofi Pasteur Latest Developments
List of Figures
Figure 1. Picture of Zoster Vaccine
Figure 2. Zoster Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Zoster Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Zoster Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Zoster Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Live
Figure 10. Product Picture of Recombinant
Figure 11. Global Zoster Vaccine Sales Market Share by Type in 2021
Figure 12. Global Zoster Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Zoster Vaccine Consumed in Government Institution
Figure 14. Global Zoster Vaccine Market: Government Institution (2017-2022) & (K Units)
Figure 15. Zoster Vaccine Consumed in Private Sector
Figure 16. Global Zoster Vaccine Market: Private Sector (2017-2022) & (K Units)
Figure 17. Zoster Vaccine Consumed in Other
Figure 18. Global Zoster Vaccine Market: Other (2017-2022) & (K Units)
Figure 19. Global Zoster Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global Zoster Vaccine Revenue Market Share by Application in 2021
Figure 21. Zoster Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Zoster Vaccine Revenue Market Share by Company in 2021
Figure 23. Global Zoster Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Zoster Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Zoster Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global Zoster Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Zoster Vaccine Sales 2017-2022 (K Units)
Figure 28. Americas Zoster Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Zoster Vaccine Sales 2017-2022 (K Units)
Figure 30. APAC Zoster Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Zoster Vaccine Sales 2017-2022 (K Units)
Figure 32. Europe Zoster Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Zoster Vaccine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Zoster Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Zoster Vaccine Sales Market Share by Country in 2021
Figure 36. Americas Zoster Vaccine Revenue Market Share by Country in 2021
Figure 37. United States Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Zoster Vaccine Sales Market Share by Region in 2021
Figure 42. APAC Zoster Vaccine Revenue Market Share by Regions in 2021
Figure 43. China Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Zoster Vaccine Sales Market Share by Country in 2021
Figure 50. Europe Zoster Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Zoster Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Zoster Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Zoster Vaccine in 2021
Figure 64. Manufacturing Process Analysis of Zoster Vaccine
Figure 65. Industry Chain Structure of Zoster Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
